• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性血小板增多症中的血小板反应蛋白

Thrombospondin in essential thrombocythemia.

作者信息

Lawler J, Cohen A M, Chao F C, Moriarty D J

出版信息

Blood. 1986 Feb;67(2):555-8.

PMID:3510684
Abstract

Essential thrombocythemia is a myeloproliferative disorder characterized by frequent bleeding and thrombotic complications. On a molecular level, two abnormalities of platelet thrombospondin have been identified: abnormal glycosylation of the intact 185,000-dalton chain has been detected and a shortened form of the thrombospondin chain is present. We have used two monoclonal antibodies and Lens culinaris lectin to probe the structure of thrombospondin in the platelets from three patients with essential thrombocythemia; one patient with polycythemia vera and two patients with secondary thrombocytosis. The presence of abnormal thrombospondin fragments with molecular weights of 160,000 and 30,000 was detected in the intact platelets and in the supernatant from thrombin-treated platelets, in all of the individuals except one of the secondary thrombocytosis patients. Monoclonal antibody binding studies indicate that both fragments are produced by proteolysis at a single site, which results in the removal of a 30,000-dalton fragment from the NH2-terminal. Lens culinaris lectin-binding studies revealed that some of the carbohydrate moieties of thrombospondin are near this cleavage site. The results are consistent with the hypothesis that the abnormal thrombospondin fragments observed under conditions of increased platelet production are due to increased susceptibility to proteolysis which, in turn, may be due to defective glycosylation.

摘要

原发性血小板增多症是一种骨髓增殖性疾病,其特征为频繁出血和血栓形成并发症。在分子水平上,已发现血小板凝血酶敏感蛋白存在两种异常:完整的185,000道尔顿链存在异常糖基化,并且存在凝血酶敏感蛋白链的缩短形式。我们使用两种单克隆抗体和菜豆凝集素,对三名原发性血小板增多症患者、一名真性红细胞增多症患者和两名继发性血小板增多症患者的血小板中凝血酶敏感蛋白的结构进行了探测。在除一名继发性血小板增多症患者外的所有个体的完整血小板和凝血酶处理血小板的上清液中,均检测到分子量为160,000和30,000的异常凝血酶敏感蛋白片段。单克隆抗体结合研究表明,这两种片段均由在单个位点的蛋白水解产生,这导致从NH2末端去除了一个30,000道尔顿的片段。菜豆凝集素结合研究显示,凝血酶敏感蛋白的一些碳水化合物部分靠近该切割位点。这些结果与以下假设一致:在血小板生成增加的情况下观察到的异常凝血酶敏感蛋白片段是由于蛋白水解敏感性增加所致,而蛋白水解敏感性增加反过来可能是由于糖基化缺陷。

相似文献

1
Thrombospondin in essential thrombocythemia.原发性血小板增多症中的血小板反应蛋白
Blood. 1986 Feb;67(2):555-8.
2
The structure of human platelet thrombospondin.人血小板凝血酶敏感蛋白的结构。
J Biol Chem. 1985 Mar 25;260(6):3762-72.
3
The structure of endothelial cell thrombospondin. Characterization of the heparin-binding domains.内皮细胞血小板反应蛋白的结构。肝素结合域的特性。
Eur J Biochem. 1987 Oct 15;168(2):347-55. doi: 10.1111/j.1432-1033.1987.tb13426.x.
4
Structural and immunological comparison of human thrombospondins isolated from platelets and from culture supernatants of endothelial cells and fibroblasts. Evidence for a thrombospondin polymorphism.从血小板以及内皮细胞和成纤维细胞培养上清液中分离出的人血小板反应蛋白的结构和免疫学比较。血小板反应蛋白多态性的证据。
Eur J Biochem. 1986 Sep 15;159(3):569-79. doi: 10.1111/j.1432-1033.1986.tb09924.x.
5
Effect of anti-thrombospondin antibodies on the hemagglutination activities of the endogenous platelet lectin and thrombospondin.抗血小板反应蛋白抗体对内源性血小板凝集素和血小板反应蛋白血凝活性的影响。
Thromb Haemost. 1984 Dec 29;52(3):354-7.
6
Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis.
Br J Haematol. 1985 Jun;60(2):331-44. doi: 10.1111/j.1365-2141.1985.tb07419.x.
7
The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.血小板活化与功能受损的悖论:血小板与血管性血友病因子的相互作用,以及原发性血小板增多症和真性红细胞增多症中血栓形成和出血表现的病因。
Semin Thromb Hemost. 2006 Sep;32(6):589-604. doi: 10.1055/s-2006-949664.
8
Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.一种抑制人血小板功能的抗血小板反应蛋白单克隆抗体(P8)的特性。P8与凝血酶激活的血小板无力症血小板的正常结合。
Eur J Biochem. 1988 Jan 15;171(1-2):383-92. doi: 10.1111/j.1432-1033.1988.tb13802.x.
9
Thrombospondin is the endogenous lectin of human platelets.血小板反应蛋白是人类血小板的内源性凝集素。
Nature. 1982 Jan 21;295(5846):246-8. doi: 10.1038/295246a0.
10
An altered platelet granule glycoprotein in patients with essential thrombocythemia.原发性血小板增多症患者血小板颗粒糖蛋白的改变
J Clin Invest. 1984 Feb;73(2):291-7. doi: 10.1172/JCI111213.

引用本文的文献

1
Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis.血小板反应蛋白-1 通过限制细胞外基质的蛋白水解来防止病原体引起的肺损伤。
JCI Insight. 2018 Feb 8;3(3). doi: 10.1172/jci.insight.96914.
2
ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2.ADAMTS1介导从血小板反应蛋白1和2中释放抗血管生成多肽。
EMBO J. 2006 Nov 15;25(22):5270-83. doi: 10.1038/sj.emboj.7601400. Epub 2006 Nov 2.
3
The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins.
人血小板反应蛋白的结构,一种具有多个钙结合位点且与几种不同蛋白质存在同源性的黏附糖蛋白。
J Cell Biol. 1986 Nov;103(5):1635-48. doi: 10.1083/jcb.103.5.1635.